Boothbay Fund Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.28 Billion
- Q1 2025
A detailed history of Boothbay Fund Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 454,891 shares of LXRX stock, worth $404,852. This represents 0.01% of its overall portfolio holdings.
Number of Shares
454,891
Previous 480,822
5.39%
Holding current value
$404,852
Previous $355,000
41.13%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$121 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$8.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$8.51 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$7.31 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$3.28 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $168M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...